Efficacy of ABT-199 on established chronic graft-versus-host disease (GVHD) in preclinical mouse models

Project: Research project

Description

Efficacy of ABT-199 on established chronic graft-versus-host disease (GVHD) in preclinical mouse models
StatusActive
Effective start/end date10/3/1810/3/20

Funding

  • ABBVIE INC.

Fingerprint

Graft vs Host Disease
4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide